Florence Berteletti-Kemp, Director of Smoke Free Partnership, gave an update from Europe on the Tobacco Products Directive at the European Week Against Cancer conference in Dublin, Ireland on May 30th, 2013
The document discusses the European Tobacco Products Directive. Some key points:
- The Directive provides stronger regulation of tobacco products, ingredients, additives, and disclosure requirements. It aims to improve public health protection across the EU.
- Products like cigarettes, smokeless tobacco, e-cigarettes, and novel products will be regulated. Ingredients giving flavors or health impressions will be restricted. Misleading packaging and labeling will be prohibited.
- Implementation and monitoring plans include collecting industry data, tracking products, and evaluating the Directive's public health impact over 5 years using cohort and survey studies across 6 EU member states.
Ms Marie Killeen, Programme Manager of the Health and Wellbeing Programme at the Department of Health, spoke about the Government's objectives and aspirations to promote health and wellbeing in Ireland.
The document discusses the history and importance of chocolate in human civilization. It notes that chocolate originated in Mesoamerica over 3000 years ago and was prized by the Aztecs and Mayans for its taste. Cocoa beans were used as currency and their cultivation was tightly regulated. The document highlights how chocolate spread around the world following the age of exploration and is now one of the most popular flavors worldwide.
Presentation by Peter van der Mark (Secretary-General, European Smoking Tobacco Associations (ESTA)) on the occasion of the EESC hearing on Manufacture, presentation and sale of tobacco and related products (Brussels, 19 Feb 2013).
This document discusses threats facing European tobacco growers from potential new regulations. It summarizes:
1) Tobacco growers could be negatively impacted by bans on ingredients in tobacco products, bans on oral tobacco, and plain packaging requirements.
2) European tobacco growing has already decreased due to reforms to the Common Agricultural Policy and Common Market Organization that reduced subsidies. Further regulatory threats could severely impact employment and rural development in regions dependent on tobacco.
3) Bans on ingredients risk eliminating Burley and Oriental tobacco varieties grown in several EU countries, which would damage growers and eliminate over 300,000 jobs across 68,000 farms in 9 EU member states.
1) The document is a script that contrasts life in the city versus the countryside through the characters Nazish, George, Michael, and Marie.
2) In the city, Michael stabs Nazish to steal her money while she is walking behind a school. Later, George and Nazish arrest Michael and Navina for taking drugs.
3) In the countryside, Nazish and George have a happier life working on a farm and discuss getting married, having a family, and buying a house together.
Presentation by Ronan Barry (chairman of the Executive Committee and Board Member, Confederation of European Community cigarette Manufacturers (CECCM)) on the occasion of the EESC hearing on Manufacture, presentation and sale of tobacco and related products (Brussels, 19 Feb 2013)
Tobacco Products Directive by Philip MorrisDocumentsFound
Tobacco industry documents show how the industry planned its campaign against the Tobacco Products Directive (TPD). The information reveals:
I) Number of lobbyists – official and unofficial;
II) Amount of EUR spent;
III) How votes and decisions by MEPs coincide with lobbying by PMI;
IV) How lobbying was in a clear breach of the Framework Convention on Tobacco Control;
V) A PMI strategy how to influence the MEPs to fight the revision of the TPD;
VI) Lists of MEPs, their positions and their loyalties;
VII) other information to understand how the tobacco industry is getting their way.
The document discusses the European Tobacco Products Directive. Some key points:
- The Directive provides stronger regulation of tobacco products, ingredients, additives, and disclosure requirements. It aims to improve public health protection across the EU.
- Products like cigarettes, smokeless tobacco, e-cigarettes, and novel products will be regulated. Ingredients giving flavors or health impressions will be restricted. Misleading packaging and labeling will be prohibited.
- Implementation and monitoring plans include collecting industry data, tracking products, and evaluating the Directive's public health impact over 5 years using cohort and survey studies across 6 EU member states.
Ms Marie Killeen, Programme Manager of the Health and Wellbeing Programme at the Department of Health, spoke about the Government's objectives and aspirations to promote health and wellbeing in Ireland.
The document discusses the history and importance of chocolate in human civilization. It notes that chocolate originated in Mesoamerica over 3000 years ago and was prized by the Aztecs and Mayans for its taste. Cocoa beans were used as currency and their cultivation was tightly regulated. The document highlights how chocolate spread around the world following the age of exploration and is now one of the most popular flavors worldwide.
Presentation by Peter van der Mark (Secretary-General, European Smoking Tobacco Associations (ESTA)) on the occasion of the EESC hearing on Manufacture, presentation and sale of tobacco and related products (Brussels, 19 Feb 2013).
This document discusses threats facing European tobacco growers from potential new regulations. It summarizes:
1) Tobacco growers could be negatively impacted by bans on ingredients in tobacco products, bans on oral tobacco, and plain packaging requirements.
2) European tobacco growing has already decreased due to reforms to the Common Agricultural Policy and Common Market Organization that reduced subsidies. Further regulatory threats could severely impact employment and rural development in regions dependent on tobacco.
3) Bans on ingredients risk eliminating Burley and Oriental tobacco varieties grown in several EU countries, which would damage growers and eliminate over 300,000 jobs across 68,000 farms in 9 EU member states.
1) The document is a script that contrasts life in the city versus the countryside through the characters Nazish, George, Michael, and Marie.
2) In the city, Michael stabs Nazish to steal her money while she is walking behind a school. Later, George and Nazish arrest Michael and Navina for taking drugs.
3) In the countryside, Nazish and George have a happier life working on a farm and discuss getting married, having a family, and buying a house together.
Presentation by Ronan Barry (chairman of the Executive Committee and Board Member, Confederation of European Community cigarette Manufacturers (CECCM)) on the occasion of the EESC hearing on Manufacture, presentation and sale of tobacco and related products (Brussels, 19 Feb 2013)
Tobacco Products Directive by Philip MorrisDocumentsFound
Tobacco industry documents show how the industry planned its campaign against the Tobacco Products Directive (TPD). The information reveals:
I) Number of lobbyists – official and unofficial;
II) Amount of EUR spent;
III) How votes and decisions by MEPs coincide with lobbying by PMI;
IV) How lobbying was in a clear breach of the Framework Convention on Tobacco Control;
V) A PMI strategy how to influence the MEPs to fight the revision of the TPD;
VI) Lists of MEPs, their positions and their loyalties;
VII) other information to understand how the tobacco industry is getting their way.
The document summarizes the process of revising the Tobacco Products Directive (TPD) in the European Union from 2009 to 2014. It describes the TPD revision process as unusual, with a long preparatory phase and speedy adoption despite tobacco industry attempts to block or delay it. It identifies several key factors for the successful outcome, including the leadership of the DG Sanco tobacco team and certain EU presidencies, as well as unexpected events that weakened industry influence. It also highlights the important role of health and tobacco control non-governmental organizations in achieving a significant advance in tobacco product regulation through the revised TPD. The document concludes by discussing next steps, such as TPD implementation and addressing other provisions of the WHO Framework
The document summarizes the process of revising the Tobacco Products Directive (TPD) in the European Union from 2009 to 2014. It describes the TPD revision process as unusual, with a long preparatory phase and speedy adoption despite tobacco industry attempts to block or delay it. It identifies several key factors for the successful outcome, including the leadership of the DG Sanco tobacco team and certain EU presidencies, as well as unexpected events that weakened industry influence. It also highlights the important role of health and tobacco control non-governmental organizations in achieving a significant advance in tobacco product regulation through the revised TPD. The document concludes by discussing next steps, such as TPD implementation and addressing other provisions of the WHO Framework
The document discusses the Tobacco Products Directive and its priorities for review. It argues that the Directive is an opportunity to [1] implement measures that help prevent children from starting smoking, such as requiring packs that fully inform consumers about health risks and removing appealing tastes. [2] Around 80 million children in the EU are at risk of starting smoking. [3] A successful Directive with a ban on marketing techniques and additives could decrease tobacco consumption by 2% over 5 years, saving billions of euros and thousands of lives.
EU programi finansiranja i instrumenti: Koncept i praktična pripremaVladimir Djumic
This document provides an overview of the European Union accession process for neighboring countries. It discusses the EU programs and instruments used to support potential candidate countries (IPA) and European Neighborhood Policy countries (ENPI). Key points covered include the transition from IPA to IPA II, project cycle management for EU programs, and examples of cross-border cooperation in Europe. Practical lessons from visits to the Saarland parliament and the European Investment Bank in Luxembourg are also summarized.
4d campaigning with devolved governments AO community conferenceJess Day
The devolved parliaments in the UK have different political structures that require a unique campaigning approach. Campaigning in the EU can be even more complicated! The British Heart Foundation's Advocacy Manager, Julia Toft, and Scottish Advocacy Co-ordinator Ben McKendrick will look at some of the key issues related to campaigning in Scotland, Wales, and Northern Ireland, and the EU including the role and targeting or politicians elected through proportional representation, and running campaigns in different languages. The session will also look at specific tools in the e-activist platform to help with messaging, the use of re-direct options, and the use of client contact databases.
Moving the WHO FCTC Forward in its Second Decade: The Role of Evidence in St...UCT ICO
The document summarizes evidence from the International Tobacco Control Policy Evaluation Project (ITC Project) on the impact of health warnings on tobacco packaging. The ITC Project finds that large pictorial health warnings are more effective than text-only warnings at increasing awareness of health risks, motivating smoking cessation, and preventing smoking initiation. Studies from Australia, Thailand, Malaysia, and other countries show that implementing large graphic warnings significantly increases noticing of warnings and discourages cigarette consumption. Transitioning China from small text warnings to larger graphic warnings based on evidence from Malaysia could potentially impact the smoking behaviors of tens of millions of Chinese smokers.
This document announces a workshop on parallel trade management strategies taking place on February 13th, 2017 in London. The workshop will be led by Janice Haigh and will discuss short and long-term concerns of pharmaceutical manufacturers, regulators, and parallel traders regarding topics such as the EU Falsified Medicines Directive and technology trends. Attendees can register online or by phone and academic and group discounts are available.
02 the present eu institutional framework karolinyeszter
The document summarizes the key institutions and decision-making processes of the European Union. It outlines that the EU has expanded from 6 original members to 27 current members through the processes of widening membership and deepening integration. The main EU institutions discussed are the European Council, European Commission, European Parliament, Council of Ministers, Court of Justice, and Court of Auditors. It also describes the roles of these institutions and how decisions are made through various procedures like co-decision, consultation, and assent that involve different combinations of institutions.
The document summarizes tobacco control instruments at the European level. It discusses specific legislation like directives and recommendations. It also discusses how tobacco control relates to other policies around trade, taxation, agriculture, research, customs, and development. The document mentions the Framework Convention on Tobacco Control and its various articles. It also briefly discusses the EU/US trade partnership and global targets for non-communicable diseases.
The document discusses supervision and law enforcement of pharmaceutical marketing in the Netherlands. It describes the country's regulatory framework, the roles of different regulators like the Health Care Inspectorate and codes of conduct organizations. It also outlines enforcement options for minor, intermediate, and serious violations ranging from self-regulatory measures to fines. Complications around areas like disease mongering and conflicts of interest in clinical guidelines are also mentioned.
The Council adopted conclusions and negotiating directives on a "green goods initiative" for the liberalisation of trade in environmental goods.
Welcoming this initiative by WTO members, the Council called for a rapid start to negotiations as the first step towards establishing it on multilateral basis. It expressed support for the elimination of tariffs on a broad range of products that contribute to green growth, environmental protection and sustainable development. It emphasised the need to explore the ground for the liberalisation of environmental services, including trade-related services, and to address non-tariff barriers to environmental goods and services.
This document summarizes the objectives, methodology, key facts, results, and messages of the EUROPLAN WP8 project, which involved organizing 15 national conferences on rare diseases across Europe. The conferences aimed to promote national plans for rare diseases based on EU guidelines. Over 2,200 stakeholders participated, including patients, healthcare professionals, researchers, and policymakers. The conferences helped raise awareness of rare diseases and validated the EU recommendations at the national level. Discussion focused on improving care, research, coding, and patient empowerment based on each country's system. The project was seen as highly effective in advancing rare disease policy across Europe.
Maria Teresa Scardigli, vice president with Kellen Europe, presented "Europe Today" on November 14, 2008 in Washington, DC at ASAE and The Center. She discussed Brussels and the European Union, the European political situation, specific European initiatives and association trends in Europe.
This document discusses the establishment of Single Points of Contact (SPOCs) systems globally to facilitate cooperation against counterfeit medical products. It describes the Council of Europe's work establishing SPOC networks, including providing training to authorities and maintaining a database. The European Directorate for the Quality of Medicines & HealthCare has trained officials from over 40 countries. The document also outlines provisions in the MEDICRIME Convention supporting cooperation between competent authorities through SPOCs.
Rapport de la Commission Européenne sur la consultation publique relative au traité de libre-échange transatlantique et au mécanisme d'arbitrage international de janvier 2015.
This document provides an agenda and details for the "Anti-Counterfeiting Pharma 2015" conference taking place on March 11-12, 2015 in London. The conference will feature presentations and panel discussions on topics related to anti-counterfeiting strategies in the pharmaceutical industry, including serialisation, supply chain security, legislation, mobile technologies, and tackling online pharmaceutical crime. Prominent speakers will represent organizations such as Sanofi, Shire Pharmaceuticals, MHRA, GS1, and Arnold & Porter LLP. Attendees will include professionals from R&D, supply chain, packaging, and other relevant roles within the pharmaceutical industry.
Disadvantages of Transatlantic Trade and Investment PartnershipMirjonNikGegvataj
The document outlines some potential disadvantages of the proposed EU-USA trade deal known as the Transatlantic Trade and Investment Partnership (TTIP). It notes concerns that the deal could undermine democracy, labor standards, and national sovereignty through investor-state dispute settlement mechanisms. It also lists concerns regarding potential negative impacts on small and medium businesses, public health services, consumer protections, food safety, the environment, and intellectual property rules.
British American Tobacco has implemented various CSR initiatives including donations, establishing a CSR center at the University of Nottingham, education programs in Africa, audited social reports, and stakeholder engagement. Their CSR strategy focuses on harm reduction through less toxic products and sustainable agriculture while ensuring responsible corporate behavior. Critics argue that tobacco use still causes significant health and environmental issues globally despite these initiatives.
Plasma 25-Hydroxyvitamin D Concentration, VDR polymorphisms and their Interac...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Plasma 25-Hydroxyvitamin D Concentration, VDR polymorphisms and their Interaction are Associated with Survival in Colorectal Cancer Patients - Lina Zgaga
The International Classification of Functioning (ICF) Core Set for breast can...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
The International Classification of Functioning (ICF) Core Set for breast cancer – a prospective surveillance tool to identify rehabilitation needs - Marese Cooney
More Related Content
Similar to Florence Berteletti-Kemp - Tobacco Products Directive
The document summarizes the process of revising the Tobacco Products Directive (TPD) in the European Union from 2009 to 2014. It describes the TPD revision process as unusual, with a long preparatory phase and speedy adoption despite tobacco industry attempts to block or delay it. It identifies several key factors for the successful outcome, including the leadership of the DG Sanco tobacco team and certain EU presidencies, as well as unexpected events that weakened industry influence. It also highlights the important role of health and tobacco control non-governmental organizations in achieving a significant advance in tobacco product regulation through the revised TPD. The document concludes by discussing next steps, such as TPD implementation and addressing other provisions of the WHO Framework
The document summarizes the process of revising the Tobacco Products Directive (TPD) in the European Union from 2009 to 2014. It describes the TPD revision process as unusual, with a long preparatory phase and speedy adoption despite tobacco industry attempts to block or delay it. It identifies several key factors for the successful outcome, including the leadership of the DG Sanco tobacco team and certain EU presidencies, as well as unexpected events that weakened industry influence. It also highlights the important role of health and tobacco control non-governmental organizations in achieving a significant advance in tobacco product regulation through the revised TPD. The document concludes by discussing next steps, such as TPD implementation and addressing other provisions of the WHO Framework
The document discusses the Tobacco Products Directive and its priorities for review. It argues that the Directive is an opportunity to [1] implement measures that help prevent children from starting smoking, such as requiring packs that fully inform consumers about health risks and removing appealing tastes. [2] Around 80 million children in the EU are at risk of starting smoking. [3] A successful Directive with a ban on marketing techniques and additives could decrease tobacco consumption by 2% over 5 years, saving billions of euros and thousands of lives.
EU programi finansiranja i instrumenti: Koncept i praktična pripremaVladimir Djumic
This document provides an overview of the European Union accession process for neighboring countries. It discusses the EU programs and instruments used to support potential candidate countries (IPA) and European Neighborhood Policy countries (ENPI). Key points covered include the transition from IPA to IPA II, project cycle management for EU programs, and examples of cross-border cooperation in Europe. Practical lessons from visits to the Saarland parliament and the European Investment Bank in Luxembourg are also summarized.
4d campaigning with devolved governments AO community conferenceJess Day
The devolved parliaments in the UK have different political structures that require a unique campaigning approach. Campaigning in the EU can be even more complicated! The British Heart Foundation's Advocacy Manager, Julia Toft, and Scottish Advocacy Co-ordinator Ben McKendrick will look at some of the key issues related to campaigning in Scotland, Wales, and Northern Ireland, and the EU including the role and targeting or politicians elected through proportional representation, and running campaigns in different languages. The session will also look at specific tools in the e-activist platform to help with messaging, the use of re-direct options, and the use of client contact databases.
Moving the WHO FCTC Forward in its Second Decade: The Role of Evidence in St...UCT ICO
The document summarizes evidence from the International Tobacco Control Policy Evaluation Project (ITC Project) on the impact of health warnings on tobacco packaging. The ITC Project finds that large pictorial health warnings are more effective than text-only warnings at increasing awareness of health risks, motivating smoking cessation, and preventing smoking initiation. Studies from Australia, Thailand, Malaysia, and other countries show that implementing large graphic warnings significantly increases noticing of warnings and discourages cigarette consumption. Transitioning China from small text warnings to larger graphic warnings based on evidence from Malaysia could potentially impact the smoking behaviors of tens of millions of Chinese smokers.
This document announces a workshop on parallel trade management strategies taking place on February 13th, 2017 in London. The workshop will be led by Janice Haigh and will discuss short and long-term concerns of pharmaceutical manufacturers, regulators, and parallel traders regarding topics such as the EU Falsified Medicines Directive and technology trends. Attendees can register online or by phone and academic and group discounts are available.
02 the present eu institutional framework karolinyeszter
The document summarizes the key institutions and decision-making processes of the European Union. It outlines that the EU has expanded from 6 original members to 27 current members through the processes of widening membership and deepening integration. The main EU institutions discussed are the European Council, European Commission, European Parliament, Council of Ministers, Court of Justice, and Court of Auditors. It also describes the roles of these institutions and how decisions are made through various procedures like co-decision, consultation, and assent that involve different combinations of institutions.
The document summarizes tobacco control instruments at the European level. It discusses specific legislation like directives and recommendations. It also discusses how tobacco control relates to other policies around trade, taxation, agriculture, research, customs, and development. The document mentions the Framework Convention on Tobacco Control and its various articles. It also briefly discusses the EU/US trade partnership and global targets for non-communicable diseases.
The document discusses supervision and law enforcement of pharmaceutical marketing in the Netherlands. It describes the country's regulatory framework, the roles of different regulators like the Health Care Inspectorate and codes of conduct organizations. It also outlines enforcement options for minor, intermediate, and serious violations ranging from self-regulatory measures to fines. Complications around areas like disease mongering and conflicts of interest in clinical guidelines are also mentioned.
The Council adopted conclusions and negotiating directives on a "green goods initiative" for the liberalisation of trade in environmental goods.
Welcoming this initiative by WTO members, the Council called for a rapid start to negotiations as the first step towards establishing it on multilateral basis. It expressed support for the elimination of tariffs on a broad range of products that contribute to green growth, environmental protection and sustainable development. It emphasised the need to explore the ground for the liberalisation of environmental services, including trade-related services, and to address non-tariff barriers to environmental goods and services.
This document summarizes the objectives, methodology, key facts, results, and messages of the EUROPLAN WP8 project, which involved organizing 15 national conferences on rare diseases across Europe. The conferences aimed to promote national plans for rare diseases based on EU guidelines. Over 2,200 stakeholders participated, including patients, healthcare professionals, researchers, and policymakers. The conferences helped raise awareness of rare diseases and validated the EU recommendations at the national level. Discussion focused on improving care, research, coding, and patient empowerment based on each country's system. The project was seen as highly effective in advancing rare disease policy across Europe.
Maria Teresa Scardigli, vice president with Kellen Europe, presented "Europe Today" on November 14, 2008 in Washington, DC at ASAE and The Center. She discussed Brussels and the European Union, the European political situation, specific European initiatives and association trends in Europe.
This document discusses the establishment of Single Points of Contact (SPOCs) systems globally to facilitate cooperation against counterfeit medical products. It describes the Council of Europe's work establishing SPOC networks, including providing training to authorities and maintaining a database. The European Directorate for the Quality of Medicines & HealthCare has trained officials from over 40 countries. The document also outlines provisions in the MEDICRIME Convention supporting cooperation between competent authorities through SPOCs.
Rapport de la Commission Européenne sur la consultation publique relative au traité de libre-échange transatlantique et au mécanisme d'arbitrage international de janvier 2015.
This document provides an agenda and details for the "Anti-Counterfeiting Pharma 2015" conference taking place on March 11-12, 2015 in London. The conference will feature presentations and panel discussions on topics related to anti-counterfeiting strategies in the pharmaceutical industry, including serialisation, supply chain security, legislation, mobile technologies, and tackling online pharmaceutical crime. Prominent speakers will represent organizations such as Sanofi, Shire Pharmaceuticals, MHRA, GS1, and Arnold & Porter LLP. Attendees will include professionals from R&D, supply chain, packaging, and other relevant roles within the pharmaceutical industry.
Disadvantages of Transatlantic Trade and Investment PartnershipMirjonNikGegvataj
The document outlines some potential disadvantages of the proposed EU-USA trade deal known as the Transatlantic Trade and Investment Partnership (TTIP). It notes concerns that the deal could undermine democracy, labor standards, and national sovereignty through investor-state dispute settlement mechanisms. It also lists concerns regarding potential negative impacts on small and medium businesses, public health services, consumer protections, food safety, the environment, and intellectual property rules.
British American Tobacco has implemented various CSR initiatives including donations, establishing a CSR center at the University of Nottingham, education programs in Africa, audited social reports, and stakeholder engagement. Their CSR strategy focuses on harm reduction through less toxic products and sustainable agriculture while ensuring responsible corporate behavior. Critics argue that tobacco use still causes significant health and environmental issues globally despite these initiatives.
Similar to Florence Berteletti-Kemp - Tobacco Products Directive (20)
Plasma 25-Hydroxyvitamin D Concentration, VDR polymorphisms and their Interac...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Plasma 25-Hydroxyvitamin D Concentration, VDR polymorphisms and their Interaction are Associated with Survival in Colorectal Cancer Patients - Lina Zgaga
The International Classification of Functioning (ICF) Core Set for breast can...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
The International Classification of Functioning (ICF) Core Set for breast cancer – a prospective surveillance tool to identify rehabilitation needs - Marese Cooney
Developing a national strategy for research into cancer survivorship in the U...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Developing a national strategy for research into cancer survivorship in the UK - Dr Jim Elliott (UK NCRI)
Physical and psychological side-effects following prostate cancer treatments ...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Physical and psychological side-effects following prostate cancer treatments - Heather Kinnear
Cancer Survivorship: longer term issues and the role of primary care - Prof E...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Cancer Survivorship: longer term issues and the role of primary care - Prof Eila Watson (Oxford Brookes University).
Quality of Life of Head and Neck Cancer Survivors in Urban and Rural Ireland ...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Quality of Life of Head and Neck Cancer Survivors in Urban and Rural Ireland - Audrey Thomas
Markers of low socio-economic status and lack of social support are associate...Irish Cancer Society
A presentation given at the Irish Cancer Society's Survivorship Research Day at the Aviva Stadium, Dublin on Thursday, September 20th, 2013.
Alan O'Ceallachair, Linda Sharp, Eamonn O’Leary, Mairead Skally, Paul Hanly
Markers of low socio-economic status and lack of social support are associated with low health-related quality-of-life in colorectal cancer survivors
Developing a cancer survivorship research agenda - Prof Patricia GanzIrish Cancer Society
The document summarizes challenges and opportunities for developing a cancer survivorship research agenda. It notes that the aging population will lead to a large increase in cancer cases and survivors in coming decades. Cancer survivors often face significant physical and mental health issues. More research is needed to understand late effects of treatments and better deliver palliative care, prevention, and health promotion to survivors. Opportunities exist to form interdisciplinary teams, study symptoms and comorbidities, develop safer therapies, and test new models of survivor care. Where to start depends on available populations and expertise. Translational research integrating population health and scientific discovery is key.
Professor Sir Michael Marmot's Charles Cully Lecture on health inequalities a...Irish Cancer Society
This document discusses social determinants of health and health inequalities. It summarizes evidence that social and economic factors like income, education, employment, and housing have a significant impact on health outcomes and lifespan. Health issues like cancer, obesity, and mental health problems vary depending on socioeconomic status. Creating a fair society by addressing these social determinants through policies that support children, families, education, employment and housing can help reduce health inequities.
Hanne müller moving people bridging gaps in physical activity levels in eu...Irish Cancer Society
This document summarizes the Moving People project which aims to promote physical activity in Europe and bridge gaps between countries and socioeconomic groups. The project launched the Now We Move campaign to get 100 million more Europeans active by 2020 through raising awareness, increasing opportunities, and building capacity. Now We Move held its first MOVE Week in 2012 across 23 countries engaging over 140,000 participants in accessible events. MOVE also funded 14 pilot projects in 12 countries focusing on networking, sustainability, and quality management to empower partners to implement good practices for engaging disadvantaged groups in physical activity.
Physical Activity and Cancer, a review of innovative current research. Dr. Ni...Irish Cancer Society
Physical activity guidelines exist in many EU countries to reduce cancer risk, though only a minority meet them. Research shows physical activity lowers breast, colon, and endometrial cancer risk by 25-30%, and likely other cancers, through mechanisms like reduced body fat and inflammation. Randomized trials show exercise improves outcomes for breast cancer survivors. More research is needed on optimal dose and type of activity. Ongoing studies examine biological mechanisms and effects on recurrence, survival, and quality of life.
Moving People, Hanne Müller. European Physical Activity Promotion Forum (MOVE)Irish Cancer Society
This document discusses promoting physical activity in Europe through the Now We Move campaign. The campaign aims to get 100 million more Europeans active in sport by 2020 through raising awareness, increasing opportunities, and building advocacy. The Now We Move Week held events in 23 countries in 2012 attracting over 140,000 participants. The campaign focuses on being accessible to all ages and social groups. It also hosts an online platform to share events and initiatives. The document emphasizes increasing physical activity levels among socially disadvantaged groups through comprehensive cross-sector partnerships and capacity building programs. It highlights 14 pilot projects in 12 countries implementing good practices focused on networking, sustainability, and quality management.
Food Policy in Practice, Dr. Cliodhna Foley-Nolan, Dorector of Human Nutritio...Irish Cancer Society
This document discusses food policy and practice in Ireland. It covers three key points:
1. Food poverty and health inequalities exist in Ireland, with disadvantaged groups eating less nutritious foods and having higher rates of diet-related diseases like diabetes.
2. Recent Irish food policy developments include proposals for a sugar-sweetened beverage tax and requiring calorie labeling in restaurants. However, these policies face opposition from industry.
3. Collaboration between policymakers and practitioners is important, such as through the All Island Obesity Action Forum, which brings together government, industry, NGOs and practitioners to address these issues.
Tackling Obesity in Ireland, Ursula O'Dwyer, Health Promotion Policy Adviser,...Irish Cancer Society
This document summarizes a presentation given at the European Week Against Cancer 2013 on lessons that can be learned from Denmark's taxation of foods high in sugar and saturated fat. The presentation discusses Denmark's taxes on sugar-sweetened beverages and confectionary since 2010, as well as its short-lived tax on saturated fat in foods from 2011 to 2013. It provides estimates of the impact of these taxes and discusses the political and administrative challenges that ultimately led to the repeal of the saturated fat tax. The presentation concludes that health-motivated food taxes can affect consumption but that they must have expert backing, address economic and political concerns, and impose minimal administrative burdens.
Lessons to be Learned from the Danish Food Taxations, Jorgen Dejgaard JensenIrish Cancer Society
The document summarizes lessons learned from food taxation policies in Denmark, including taxes on sugar and saturated fat. It discusses the Danish tax on saturated fat that was introduced in 2011 but abolished in 2013. The saturated fat tax aimed to reduce consumption and generate tax revenues but faced political and administrative challenges. The document concludes that health-motivated food taxes require transparency, expertise, recognition of potential benefits, and consideration of economic and political factors to be effective.
Engaging Men in Physical Activity, Sandra Gordon, Cancer Focus Northern Irela...Irish Cancer Society
The document discusses strategies for engaging men in physical activity programs. It outlines the ManAlive Project which aims to improve men's physical and mental health through health checks, education, and social activities. Key factors for engaging men include using existing community partners like sports clubs, recruiting through word-of-mouth, offering health incentives, and ensuring programs are convenient, private, and developed based on men's input. The goal is to create a supportive environment and adopt a positive, solution-focused approach to men's health.
Making the Tobacco Industry Pay, Ms. Rachel Foley - European Week Against Ca...Irish Cancer Society
This document discusses proposals to regulate tobacco prices in Ireland in order to reduce tobacco industry profits and increase government tax revenue. It argues that the tobacco industry has significant pricing power and profits due to their oligopolistic market structure. The proposals would establish a tobacco regulator to cap industry profits at a certain percentage and use the additional revenue to further tobacco control efforts. This could generate an estimated additional €41-60 million per year for the government. The document also discusses ways to strengthen tobacco tax policies, such as increasing specific excise taxes, implementing annual tax escalators, taxing hand-rolled tobacco similarly to manufactured cigarettes, and improving measures against smuggling.
Standard packs aim to reduce the appeal of tobacco products and weaken brand attachment. Evidence shows plain packaging leads to packs being seen as less attractive and having a poorer image. The tobacco industry strongly opposes plain packs as it reduces profits, but their arguments against it are weak. Advocates need to continue building support through various advocacy tools like gaining media coverage, developing partnerships, and rebutting industry claims in order to implement standard packs.
This document discusses health inequalities related to smoking. It notes that smoking rates are higher among socioeconomically disadvantaged groups and this contributes to inequalities in cancer rates and life expectancy. Smoking is associated with accumulated health risks over a lifetime. Those from more disadvantaged backgrounds are more likely to start smoking at a younger age, smoke more heavily, and are less likely to successfully quit. Addressing tobacco-related health inequalities requires a comprehensive approach that considers industry targeting of vulnerable groups and provides improved access to smoking cessation resources.
This document summarizes Scotland's experience addressing alcohol-related harms and the key factors in their progress. It discusses:
- Rising alcohol deaths in Scotland from 1980-2003 and the strategic aims of the alcohol industry to influence policymaking.
- Scotland's minimum unit pricing legislation being challenged but ultimately upheld in court as an appropriate health measure.
- Early signs that alcohol deaths in Scotland have started falling after 20 years of increases, potentially helped by the recession.
- Lessons learned including using data, having an overall strategy while focusing on priorities, involving different organizations based on their strengths, and understanding industry obligations while needing both luck and skill as progress does not end.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
1. Tobacco Products Directive:
an update from Europe
European Week Against Cancer 2013
30th May 2013
Florence Berteletti Kemp
SFP Director
2. This Presentation
1. What is the Smoke Free Partnership?
2. Background: TC instruments at EU level
3. TPD Priorities
4. What are the myths?
5. What has happened so far?
6. What is happening now?
7. What you need to do
8. Conclusions
3. This Presentation
1. What is the Smoke Free Partnership?
2. Background: TC instruments at EU level
3. TPD Priorities
4. What are the myths?
5. What has happened so far?
6. What is happening now?
7. What you need to do
8. Conclusions
4.
5. This Presentation
1. What is the Smoke Free Partnership?
2. Background: TC instruments at EU level
3. TPD Priorities
4. What are the myths?
5. What has happened so far?
6. What is happening now?
7. What you need to do
8. Conclusions
6. Specific legislation:
•Directives
•Recommendations
Tobacco control in other
policies:
•Taxation
•Agriculture
•Research
•Customs (illicit trade)
•Development
FCTC
Public Health
Programme
Ex Smokers
are
unstoppable
Art 13
Art 11
Art
9/10
Art 8
Art 6
Art 15
Art
17/18
Art 22
Art 26
Art 12
Art 14
….
Revision of the
Tobacco Products
Directive:
Unique opportunity that
won’t come back for
another 15 years!!!
Background: TC instruments at EU level
7. This Presentation
1. What is the Smoke Free Partnership?
2. Background: TC instruments at EU level
3. TPD Priorities
4. What are the myths?
5. What has happened so far?
6. What is happening now?
7. What you need to do
8. Conclusions
8. The policy priorities
• Labelling and packaging +
quitlines + TNCO
• Ban of ingredients and
additives which increase
attractiveness of tobacco
products
• Ban on Point of Sale display
• Maintain the status quo on
smokeless tobacco
9. TOP Priority for the TPD review
To prevent young
people from picking
up the habit….
10. This Presentation
1. What is the Smoke Free Partnership?
2. Background: TC instruments at EU level
3. TPD Priorities
4. What are the myths?
5. What has happened so far?
6. What is happening now?
7. What you need to do
8. Conclusions
11. Key misconceptions due to industry
lobbying
TPD proposal =
Increased illicit trade
TPD proposal =
farmers go out of
business
Plain packaging =
bad for retailers and
loss of jobs
12. Key misconceptions due to industry
lobbying
TPD proposal
introduces barriers to
trade
TPD proposal fails to
achieve internal
market objectives
Vague provision in art
12 on brand elements
Against competition
law and does not
improve the internal
market
13.
14. This Presentation
1. What is the Smoke Free Partnership?
2. Background: TC instruments at EU level
3. TPD Priorities
4. What are the myths?
5. What has happened so far?
6. What is happening now?
7. What you need to do
8. Conclusions
16. This Presentation
1. What is the Smoke Free Partnership?
2. Background: TC instruments at EU level
3. TPD Priorities
4. What are the myths?
5. What has happened so far?
6. What is happening now?
7. What you need to do
8. Conclusions
17.
18. What is happening now?
• European Parliament has started deliberations
– Cut-off date: March 2014, last EP session
– European Elections: May 2014
• Member states discussing in Council working
group
– Political agreement hoped / needed for end of the
year
– Irish Presidency doing a fabulous job!
19. Ireland GreeceLithuania
+/- 25 Council WG
meetings planned in 2013
by IE and LT presidencies
National
positions and
negotiation lines
Unclear whether a
priority…
Negotiations for a
compromise
19 Dec
2012 -
proposal
May 2014 -
European
elections
Mar 2014 -
Last EP
plenary of
this
mandate
Dec
Health
Council
June
Health
Council
20. EP timetable
TPD Public Hearing - 25 February 2013
Exchange of views in ENVI without
document - 21 March
Deadline for sending Rapporteur's text to
translation - 28 March
Consideration in ENVI - 24/25 April
Deadline amendments - 6 May at 3 pm
Exchange of views on Amendments -
29/30 May
Adoption in ENVI - 10-11 July 2013
• Plenary Vote - September 2013
Committee for the Environment, Public Health and Food Safety (ENVI)
Martin
CALLANAN
ECR, UK
Oreste
ROSSI
EFD, IT
Carl
SCHLYTER
Greens, SE
Frédérique
RIES
ALDE, BE
Karl-Heinz
FLORENZ
EPP, DE
Linda
McAVAN
S&D, UK
Martina
ANDERSON
GUE/NGL, IE
21. EP timetable
Exchange of views / presentation of the
Proposal / Impact Assessment - 21 March 2013
Deadline to send the draft opinion to translation
- 27 March 2013
Consideration of draft opinion - 24-25 April 2013
Deadline for amendments - 6 May 2013, 12:00
Consideration of amendments - 29-30 May 2013
Adoption in IMCO - 17-18 June 2013
Committee for the Internal Market and Consumer Protection (IMCO)
Małgorzata
HANDZLIK
EPP, PL
Christian
ENGSTRÖM
Greens, SE
TBC
Other shadow
rapporteurs for
S&D, ALDE, ECR, G
UE, and EFD
22. EP timetable
Industry, Research and
Energy committee (ITRE)
Legal Affairs Committee
(JURI)
Agriculture and rural
Development Committee
(AGRI)
• Examination in
Committee - 13 May
2013
Adoption in ITRE – 20
June 2013
• Examination in
Committee - 24 April
2013
Deadline for
amendments – 26
April 2013
Adoption in AGRI – 29
May 2013
• Deadline for
amendments 3rd June
Shadow rapporteurs
TBC for other groups
Klaus-Heiner
LEHNE
EPP, DE
Csaba Sándor
TABAJDI
S&D, HU
Robert
GOEBBELS
S&D, LUX
23. This Presentation
1. What is the Smoke Free Partnership?
2. Background: TC instruments at EU level
3. TPD Priorities
4. What are the myths?
5. What has happened so far?
6. What is happening now?
7. What you need to do
8. Conclusions
24. What you need to do?
• Coordination is key
• Use the SFP myth buster
and develop your own
• Be clear on the top
priorities and don’t
expect to win on every
front
25. What you need to do?
• Send letter to ENVI MEPS with
top amendments a week
before 11 July
• Send message to all MEPS
with top amendments a week
before Plenary vote (on 11 or
12 September)
26. This Presentation
1. What is the Smoke Free Partnership?
2. Background: TC instruments at EU level
3. TPD Priorities
4. What are the myths?
5. What has happened so far?
6. What is happening now?
7. What you need to do
8. Conclusions
Good afternoon, ladies and gentlemen, distinguished participants. Before I start my presentation, I would like to pay tribute to the organisations that support the Smoke Free Partnership. These organisations are the European Respiratory Society, Cancer Research UK, the European Heart Network and Ash UK. I would also like to specially and warmly thank the Irish Cancer Society for their special support to SFP during 2013. I certainly hope that this partnership will continue. I would also like to acknowledge the close collaboration with ECL.
At EU level (from now to 2014):Revision of the Tobacco Products Directive and possibility to introduce LARGE mandatory pictorial warnings and plain packagingAt EU level (from 2014 to 2019)Revision of the Tobacco Tax Directive
Time : we want the directive adopted before 2014 EP electionsContent: we want a good legislation to emerge from the adoption processNeed to move fast and in a coordinated manner
Use the Myth BusterRead our legal analysis
Remember that the industry does not have any evidence based arguments – certainly not peer reviewed = they are just very good salemen!
Consultation – 85,000 responses Analysis doneImpact assessment done = 1000 pagesInter-service consultation completedDalli resignation Borg appointment TPD proposal released on the 19th of December 2012
Intense lobbying from the tobacco industry and its front groups and alliesHigh political sensitivityHigh media pressureThe political agenda has changed dramatically in the last 6 months and continues to changeKeeping the focus on the key priorities will be a challenge“What’s the hurry?” “National impact assessment” “Not the time to threaten jobs”
JorgoChatzimarkakisALDEDEMałgorzataHandzlikEPPPLAdam BielanECRCZAndreas SchwabEPPATDennis (Cornelis) de JongGUE/NGLNLEdvard Kožušník (Deputy)ECRCZEvelyne GebhardtS&DNLToineMandersALDENLMatteo SalviniEFDITHeideRühleGreens/EFADE
The public is on our sideThe data and evidence – both scientific and from practiceFCTC obligations provide the answer and its guidelines are the best practiceThe public health and tobacco control communityThe scientific and medical community
How do we make it happen?Coordination is keyUse the myth buster and develop your ownPay attention to Article 24 and 13Be clear on the top priorities and don’t expect to win on every front